Oxford Nanopore Technologies (ONT) RNS Announcements

Add to Alert list
Date Time Source Announcement
01 Mar 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
24 Feb 2022 07:00 AM
RNS
Notice of Results
11 Feb 2022 05:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Feb 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
24 Jan 2022 03:00 PM
RNS
Appointment of Senior Independent Director
18 Jan 2022 01:00 PM
RNS
Holding(s) in Company
13 Jan 2022 07:00 AM
RNS
Fastest human genome sequence uses Oxford Nanopore
11 Jan 2022 06:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
07 Jan 2022 12:00 PM
RNS
Update to FY21 revenue guidance
07 Jan 2022 07:00 AM
RNS
Company to present at JP Morgan Healthcare conf
04 Jan 2022 06:30 PM
RNS
Issue of Equity and Total Voting Rights
20 Dec 2021 05:00 PM
RNS
Holding(s) in Company
13 Dec 2021 06:15 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
02 Dec 2021 07:00 AM
RNS
Oxford Nanopore announces technology updates
01 Dec 2021 07:00 AM
RNS
Issue of Equity and Total Voting Rights
09 Nov 2021 07:03 AM
RNS
Update to revenue guidance
03 Nov 2021 06:00 PM
RNS
Holding(s) in Company
01 Nov 2021 06:30 PM
RNS
PDMR Notification (ESPP) and Director Declaration
01 Nov 2021 07:00 AM
RNS
Issue of Equity and Total Voting Rights
14 Oct 2021 05:33 PM
RNS
Upgrade to full-year revenue guidance
13 Oct 2021 06:20 PM
RNS
Share Incentive Plan, Director/PDMR Transactions
08 Oct 2021 12:00 PM
RNS
Exercise of Over-allotment Option
08 Oct 2021 07:00 AM
RNS
Total Voting Rights
08 Oct 2021 07:00 AM
RNS
Notification of Transactions of Director/PDMR
07 Oct 2021 06:00 PM
RNS
Holding(s) in Company
07 Oct 2021 06:00 PM
RNS
Holding(s) in Company
07 Oct 2021 06:00 PM
RNS
Holding(s) in Company
05 Oct 2021 03:45 PM
RNS
Total Voting Rights
05 Oct 2021 03:45 PM
RNS
Block Listing Application/Directorate Change
05 Oct 2021 07:00 AM
RNS
Admission to Trading on the London Stock Exchange
04 Oct 2021 05:51 PM
RNS
Exercise of Over-allotment Option
30 Sep 2021 01:13 PM
RNS
Approval and Publication of Prospectus
30 Sep 2021 07:00 AM
RNS
Announcement of Offer Price
20 May 2004 06:09 PM
RNS
Holding(s) in Company
06 May 2004 03:35 PM
RNS
Directorate Change
30 Apr 2004 04:43 PM
RNS
Cancellation of admission
23 Mar 2004 05:44 PM
RNS
Holding(s) in Company
18 Mar 2004 12:00 PM
RNS
Result of AGM
03 Mar 2004 11:36 AM
RNS
Rule 2.10 Announcement
20 Feb 2004 05:22 PM
RNS
Holding in Company
18 Feb 2004 12:40 PM
RNS
Holding in Company
12 Feb 2004 04:22 PM
RNS
Holding in Company
05 Feb 2004 07:00 AM
PRN
Re Contract
16 Jan 2004 11:14 AM
RNS
Holding(s) in Company
13 Jan 2004 02:54 PM
RNS
Grant of Options
12 Jan 2004 05:32 PM
RNS
Holding in Company
09 Jan 2004 09:42 AM
PRN
Director Shareholding
08 Jan 2004 10:15 AM
PRN
EGM Statement
16 Dec 2003 07:00 AM
RNS
Final Results
16 Dec 2003 07:00 AM
RNS
Statement re: Placing

Oxford Nanopore Technologies develops electronic sensing systems for analyzing DNA, RNA, proteins, and other molecules including DNA sequencing, diagnostics and drug development using uses nanopore science to develop single-molecule sensing systems. Their products are used in research areas such as microbiology, human genetics, cancer research, and plant research.

Founded in 2005 as a spin-out from the University of Oxford, Oxford Nanopore is listed in London under the ticker ONT.

Oxford Nanopore share price listed at 615p in 2021.

UK 100

Latest directors dealings